S2, E1: Mana.bio and programmable lipid nanoparticles with CEO Yogev Debbi and RNA expert Dr Barry Ticho episode artwork

EPISODE · May 14, 2024 · 33 MIN

S2, E1: Mana.bio and programmable lipid nanoparticles with CEO Yogev Debbi and RNA expert Dr Barry Ticho

from Raising Biotech · host Surani Fernando

In this episode of Raising Biotech, Surani explores the multi-layered start-up story of Israeli lipid nanoparticle biotech Mana.bio. This is a tech meets biotech story, where AI and machine learning is being leveraged to develop novel lipid nanoparticle formulations to get nucleic-acid based therapies (DNA, RNA, CRISPR) to hard to reach organs. The company announced a $19.5 million seed financing in October 2023, and its exciting new chapter was heavily impacted by the October 7 Hamas attacks in Israel. CEO Yogev Debbi gives his tech backstory, decision to move into life-sciences, fundraising journey, what it was like to suddenly navigate a company launch as a wartime CEO and future visions to grow Mana through partnerships and a pipeline. Dr Barry Ticho, a veteran big pharma executive and chief medical officer at Stoke Therapeutics, also joins the podcast to give his expert take on Mana's scientific thesis, competitive edge, challenges ahead and future potential to advance the world of gene therapy. Timestamps: 00:35 - Partner segment: Mindgram.ai 01:05 - Background of Mana.bio and lipid nanoparticle thesis 05:30 - CEO Yogev Debbi's tech origins, backstory and Mana.bio formation 08:15 - Mana's initial work and "reverse due-diligence" fundraising journey 11:15 - Launching the company during an unexpected outbreak of war 19:25 - Industry expert perspective (Barry Ticho) on Mana's scientific and business thesis 21:55 - Competitive advantage of using AI to optimize the lipid nanoparticle design 23:40 - Which organs can these lipid nanoparticles reach in mouse models and non-human primates? 27:15 - De-risking events, challenges ahead and safety assurances 29:15 - Advantages of tackling new-age biotech with a tech background 30:24 - Mana's future business plans: comprehensive partnerships and building a pipeline This episode is partnered with Mindgram.ai, a research tool powered by AI to better serve the biopharma community. Listeners of the Raising Biotech podcast are able to get an exclusive free trial of Mindgram via this link, using the code: raisingbiotech24 For any comments, questions, feedback or suggestions you can connect directly with Surani Fernando on LinkedIn or email: [email protected] Music composed by: Yrii Semchyshyn (Coma Media) Hosted on Acast. See acast.com/privacy for more information.

In this episode of Raising Biotech, Surani explores the multi-layered start-up story of Israeli lipid nanoparticle biotech Mana.bio. This is a tech meets biotech story, where AI and machine learning is being leveraged to develop novel lipid nanoparticle formulations to get nucleic-acid based therapies (DNA, RNA, CRISPR) to hard to reach organs. The company announced a $19.5 million seed financing in October 2023, and its exciting new chapter was heavily impacted by the October 7 Hamas attacks in Israel. CEO Yogev Debbi gives his tech backstory, decision to move into life-sciences, fundraising journey, what it was like to suddenly navigate a company launch as a wartime CEO and future visions to grow Mana through partnerships and a pipeline. Dr Barry Ticho, a veteran big pharma executive and chief medical officer at Stoke Therapeutics, also joins the podcast to give his expert take on Mana's scientific thesis, competitive edge, challenges ahead and future potential to advance the world of gene therapy. Timestamps: 00:35 - Partner segment: Mindgram.ai 01:05 - Background of Mana.bio and lipid nanoparticle thesis 05:30 - CEO Yogev Debbi's tech origins, backstory and Mana.bio formation 08:15 - Mana's initial work and "reverse due-diligence" fundraising journey 11:15 - Launching the company during an unexpected outbreak of war 19:25 - Industry expert perspective (Barry Ticho) on Mana's scientific and business thesis 21:55 - Competitive advantage of using AI to optimize the lipid nanoparticle design 23:40 - Which organs can these lipid nanoparticles reach in mouse models and non-human primates? 27:15 - De-risking events, challenges ahead and safety assurances 29:15 - Advantages of tackling new-age biotech with a tech background 30:24 - Mana's future business plans: comprehensive partnerships and building a pipeline This episode is partnered with Mindgram.ai, a research tool powered by AI to better serve the biopharma community. Listeners of the Raising Biotech podcast are able to get an exclusive free trial of Mindgram via this link, using the code: raisingbiotech24 For any comments, questions, feedback or suggestions you can connect directly with Surani Fernando on LinkedIn or email: [email protected] Music composed by: Yrii Semchyshyn (Coma Media) Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

S2, E1: Mana.bio and programmable lipid nanoparticles with CEO Yogev Debbi and RNA expert Dr Barry Ticho

0:00 33:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

RAISING THE BAR MUSICHYPEBEAST The RAISING THE BAR Podcast is dedicated to providing a fresh and unconventional broadcast platform for the biggest names in music and entertainment.The interview insight provided by the staff of MUSICHYPEBEAST separates us from the pack. The passion of RAISING THE BAR podcast is fueled by Millennial Music culture. Hosted on Acast. See acast.com/privacy for more information. rAIsing the bar Isha Karim “rAIsing the bar” is a female-run podcast series committed to broadening the AI conversation and sparking discussion around the ethics and controversies surrounding the field today. By making AI more accessible in such an interconnected world, we aspire to foster an interest in AI for as many people as possible. Not Your Mother's Mom Group Katy Monnot and Sunnie Wicker Katy and Sunnie explore the world of motherhood online. Raising seven boys between the two of them, the only thing they know for sure is that they don't know what they're doing. And that parenting in the age of the Internet can make anyone feel inadequate. Each week they bring you their favorite questions from Internet mom groups, articles on motherhood, and a bit of personal experience as well. Talking Biotech with Dr. Kevin Folta Colabra Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.

Frequently Asked Questions

How long is this episode of Raising Biotech?

This episode is 33 minutes long.

When was this Raising Biotech episode published?

This episode was published on May 14, 2024.

What is this episode about?

In this episode of Raising Biotech, Surani explores the multi-layered start-up story of Israeli lipid nanoparticle biotech Mana.bio. This is a tech meets biotech story, where AI and machine learning is being leveraged to develop novel lipid...

Can I download this Raising Biotech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!